Suchbegriff: Lilly in Rubrik News
WDHNovo, Nordisk
WDH/Novo Nordisk erhält in den USA Tabletten-Zulassung ...
(Tippfehler im 1.
dpa.de, 23.12.25 08:20 Uhr
Viking, Therapeutics
Viking Therapeutics: El optimismo de los analistas se consolida con su fármaco contra la obesidad
boerse-global.de, 23.12.25 07:08 Uhr
Eli, Lilly
Eli Lilly se posiciona en la carrera por la pastilla contra la obesidad
boerse-global.de, 23.12.25 04:58 Uhr
Eli, Lilly’s
Eli Lilly’s Strategic Response in the Escalating Obesity Drug Race
boerse-global.de, 23.12.25 04:52 Uhr
Novo, Nordisk
Novo Nordisk Secures Landmark FDA Approval for Oral Weight-Loss Drug
boerse-global.de, 23.12.25 03:41 Uhr
Pfizer, Aktie
Pfizer senkt Umsatzprognose fĂĽr 2026 startet aber Offensive ...
Pfizer Aktie: Zwischenbilanz 2026
boerse-global.de, 22.12.25 18:44 Uhr
Novo, Nordisk
Novo Nordisk Shares Unmoved by Chinese Regulatory Win
boerse-global.de, 22.12.25 17:15 Uhr
Eli, Lilly’s
Eli Lilly’s Strategic Pivot: Acquiring Immunology Assets to Diversify Beyond Obesity Drugs
boerse-global.de, 22.12.25 16:54 Uhr
Eli, Lilly
Eli Lilly diversifica su imperio farmacĂ©utico con la mirada puesta en la inmunologĂa
boerse-global.de, 22.12.25 16:54 Uhr
Novo, Nordisk
Novo Nordisk Shares Face Mounting Challenges Amid Supply and Competitive Pressures
boerse-global.de, 22.12.25 12:11 Uhr
Eli, Lilly
Eli Lilly: Un nuevo rumbo estratégico definido por precios e inversión
boerse-global.de, 22.12.25 10:40 Uhr
ETF, MSCI
El ETF iShares MSCI World: Un Gigante con CorazĂłn TecnolĂłgico
boerse-global.de, 22.12.25 05:50 Uhr
Global, ETF
A Global ETF with a Distinctly American Tech Flavor
boerse-global.de, 22.12.25 05:49 Uhr
Eli, Lilly’s
Eli Lilly’s Strategic Maneuvers: Positioning for Market Dominance in 2026
boerse-global.de, 22.12.25 04:47 Uhr
Eli, Lilly
Eli Lilly: ÂżLa pĂldora oral que consolidará su liderazgo en obesidad?
boerse-global.de, 22.12.25 04:38 Uhr
Novo, Nordisk
Novo Nordisk Seeks US Approval for New Weight-Loss Drug Amid Pricing Shift
boerse-global.de, 22.12.25 03:41 Uhr
Novo, Nordisk’s
Novo Nordisk’s Path Forward: Can a New Drug Candidate Revive Its Prospects?
boerse-global.de, 21.12.25 16:51 Uhr
Novo, Nordisk’s
Novo Nordisk’s CagriSema: A Pivotal Asset in the Obesity Market Battle
boerse-global.de, 21.12.25 11:23 Uhr
Eli, Lilly’s
Eli Lilly’s Stock Momentum Fueled by Expanding Weight-Loss Portfolio
boerse-global.de, 21.12.25 11:15 Uhr
Eli, Lilly
Eli Lilly: La potencia farmacéutica que redefine el mercado de la obesidad
boerse-global.de, 21.12.25 11:06 Uhr
Analyst, Forecasts
Viking Therapeutics US92686J1060
Analyst Forecasts Near-Triple-Digit Upside for Viking Therapeutics Stock
boerse-global.de, 21.12.25 07:14 Uhr
Viking, Therapeutics
Viking Therapeutics: Un analista proyecta una revalorizaciĂłn del 190% en la acciĂłn
boerse-global.de, 21.12.25 07:14 Uhr
Eli, Lilly
Eli Lilly: La carrera por la pĂldora que redefine el mercado de la pĂ©rdida de peso
boerse-global.de, 21.12.25 05:04 Uhr
Eli, Lilly’s
Eli Lilly’s Oral Weight-Loss Candidate Accelerates Market Ambitions
boerse-global.de, 21.12.25 05:03 Uhr
Eli, Lilly
Eli Lilly avanza con su pĂldora para la obesidad: solicitud formal a la FDA
boerse-global.de, 20.12.25 14:08 Uhr
Eli, Lilly
Eli Lilly Seeks FDA Approval for Oral Weight-Loss Drug Candidate
boerse-global.de, 20.12.25 13:51 Uhr
Novo, Nordisk
Novo Nordisk Pins Recovery Hopes on CagriSema Combination Therapy
boerse-global.de, 20.12.25 11:46 Uhr
Eli, Lilly
Eli Lilly acelera hacia la aprobaciĂłn de su pĂldora contra la obesidad
boerse-global.de, 20.12.25 08:06 Uhr
Eli, Lilly
Eli Lilly Gains Ground in Weight-Loss Race with Accelerated Drug Review
boerse-global.de, 20.12.25 06:46 Uhr
Novo, Nordisk
Novo Nordisk Seeks FDA Approval for New Weight-Loss Drug and Higher Dose
boerse-global.de, 20.12.25 05:49 Uhr
Eli, Lilly
Eli Lilly avanza con su pĂldora oral para la pĂ©rdida de peso
boerse-global.de, 20.12.25 02:04 Uhr
Viking, Therapeutics
Viking Therapeutics: Un cĂłctel de optimismo y posiciones cortas
boerse-global.de, 19.12.25 22:46 Uhr
Hims, Hers
Hims & Hers: La apuesta de crecimiento frente al escepticismo analĂtico
boerse-global.de, 19.12.25 22:44 Uhr
Hims, Hers
Hims & Hers Stock Defies Analyst Caution with Major Facility Investment
boerse-global.de, 19.12.25 22:42 Uhr
Viking, Therapeutics
Viking Therapeutics US92686J1060
Viking Therapeutics: A Stock Poised Between High Conviction and High Short Interest
boerse-global.de, 19.12.25 22:33 Uhr
Eli, Lilly
Eli Lilly se posiciona: su pĂldora para la obesidad desafĂa el dominio de Novo Nordisk
boerse-global.de, 19.12.25 19:42 Uhr
Novo, Nordisk
Novo Nordisk Faces Pricing Pressure as Obesity Drug Awaits FDA Review
boerse-global.de, 19.12.25 18:02 Uhr
UnitedHealth, Gigante
UnitedHealth: Un Gigante Sanitario en Aguas Turbias
boerse-global.de, 19.12.25 16:36 Uhr
Eli, Lilly
Eli Lilly se posiciona en la carrera por la primera pĂldora oral contra la obesidad
boerse-global.de, 19.12.25 13:38 Uhr
Novo, Nordisk
Novo Nordisk Seeks Revival with Key Regulatory Submission
boerse-global.de, 19.12.25 13:01 Uhr
Eli, Lilly
Eli Lilly Afianza su Liderazgo con una PĂldora Revolucionaria
boerse-global.de, 19.12.25 07:24 Uhr
Eli, Lilly
Eli Lilly Strengthens Obesity Market Lead with Oral Treatment Milestone
boerse-global.de, 19.12.25 07:23 Uhr
Viking, Therapeutics
Viking Therapeutics: Un objetivo de 102 dĂłlares que gana credibilidad
boerse-global.de, 19.12.25 05:04 Uhr
Analyst, Confidence
Viking Therapeutics US92686J1060
Analyst Confidence Soars for Viking Therapeutics with $102 Price Target
boerse-global.de, 19.12.25 05:04 Uhr
Traditionelle, Chinesische
Traditionelle Chinesische Medizin punktet bei Kniearthrose und Demenz-Schmerz
boerse-global.de, 18.12.25 17:49 Uhr
Eli, Lilly’s
Eli Lilly’s Stock: Innovation Meets Pricing Pressure in Weight-Loss Drug Race
boerse-global.de, 18.12.25 17:05 Uhr
Eli, Lilly
Eli Lilly: El optimismo analĂtico se intensifica tras nuevos datos clĂnicos
boerse-global.de, 18.12.25 16:10 Uhr
Novo, Nordisk
Novo Nordisk Shares Navigate a Market of Contrasts
boerse-global.de, 18.12.25 10:54 Uhr
Eli, Lilly
Eli Lilly: Estrategia de precios para liderar el mercado de la obesidad
boerse-global.de, 18.12.25 10:08 Uhr
Strategic, Pricing
Strategic Pricing Fuels Eli Lilly’s Growth Ambitions
boerse-global.de, 18.12.25 09:09 Uhr
Eli, Lilly
Eli Lilly: Un faro en la obesidad que se atenĂşa en oncologĂa
boerse-global.de, 18.12.25 04:06 Uhr
Eli, Lilly’s
Eli Lilly’s Stock Navigates Divergent Paths in Obesity and Oncology
boerse-global.de, 18.12.25 04:05 Uhr
Novo, Nordisk
Novo Nordisk Shares Face Steep Decline Amid Market Pressures
boerse-global.de, 18.12.25 03:50 Uhr
Donanemab, Alzheimer-Antikörper
Donanemab: Alzheimer-Antikörper startet verhalten in Deutschland
boerse-global.de, 18.12.25 00:40 Uhr
Eli, Lilly
Eli Lilly: El impulso del mercado de la obesidad consolida su crecimiento
boerse-global.de, 17.12.25 16:48 Uhr
Novo, Nordisk
Novo Nordisk Shares Navigate Divergent Regional Headwinds
boerse-global.de, 17.12.25 15:22 Uhr
Eli, Lilly’s
Eli Lilly’s Stock Momentum Fueled by Obesity Drug Pipeline and Strategic Moves
boerse-global.de, 17.12.25 14:56 Uhr
Eli, Lilly
Eli Lilly: La farmacéutica que lidera la carrera de los fármacos contra la obesidad
boerse-global.de, 17.12.25 10:46 Uhr
Eli, Lilly’s
Eli Lilly’s Growth Pipeline Fuels Analyst Confidence
boerse-global.de, 17.12.25 09:53 Uhr
Eli, Lilly
Eli Lilly: Un Hito Terapéutico que Impulsa su Cotización
boerse-global.de, 17.12.25 04:44 Uhr
Eli, Lilly
Eli Lilly präsentiert überragende Phase-3-Daten für sein ...
Eli Lilly Aktie: Guter Nachrichtenfluss!
boerse-global.de, 17.12.25 04:38 Uhr
Eli, Lilly
Eli Lilly recibe un fuerte respaldo analĂtico tras datos clĂnicos excepcionales
boerse-global.de, 16.12.25 17:50 Uhr
Regulatory, Headwinds
Regulatory Headwinds Cloud Growth Outlook for Hims & Hers
boerse-global.de, 16.12.25 17:13 Uhr
Eli, Lilly
Eli Lilly Shares Surge on Analyst Upgrade and Promising Drug Data
boerse-global.de, 16.12.25 16:07 Uhr
Potential, Acquisition
A Potential Acquisition Target in the Weight-Loss Drug Race
boerse-global.de, 16.12.25 14:25 Uhr
Bellevue Asset Management AG
5 reasons for strong healthcare year in 2026
Bellevue Asset Management AG
dgap.de, 16.12.25 07:00 Uhr
Bellevue Asset Management AG
5 GrĂĽnde fĂĽr ein starkes Healthcare-Jahr 2026
Bellevue Asset Management AG
dgap.de, 16.12.25 07:00 Uhr
Contrarian, Call
A Contrarian Call: Why One Analyst Sees Value in Novo Nordisk’s Slump
boerse-global.de, 15.12.25 15:04 Uhr
Eli, Lilly’s
Eli Lilly’s Weight-Loss Pipeline Hits New Milestone with Promising Candidate
boerse-global.de, 15.12.25 13:01 Uhr
Eli, Lilly
Eli Lilly: La fortaleza de su cartera de fármacos impulsa su valoración
boerse-global.de, 15.12.25 12:16 Uhr
Eli, Lilly
Eli Lilly: Un Nuevo Hito en Terapias MetabĂłlicas Conmociona al Mercado
boerse-global.de, 15.12.25 06:14 Uhr
Hims, Hers
Hims & Hers Charts Aggressive Growth Path Amid Regulatory Headwinds
boerse-global.de, 15.12.25 05:54 Uhr
Hims, Hers
Hims & Hers: Una estrategia de diversificaciĂłn frente a la incertidumbre regulatoria
boerse-global.de, 15.12.25 05:38 Uhr
Eli, Lilly’s
Eli Lilly’s Experimental Drug Sets New Weight Loss Benchmark
boerse-global.de, 15.12.25 03:55 Uhr
Eli, Lilly’s
Eli Lilly’s Rally Gains Momentum on Strong Clinical and Institutional Support
boerse-global.de, 14.12.25 17:03 Uhr
Regulatory, Boost
Regulatory Boost for Novo Nordisk Amid Market Challenges
boerse-global.de, 14.12.25 16:25 Uhr
Eli, Lilly
Eli Lilly: Un Gigante Farmacéutico que Premia a sus Inversores
boerse-global.de, 14.12.25 16:06 Uhr
Hims, Hers
Hims & Hers: Una iniciativa legislativa pone en jaque su modelo de negocio
boerse-global.de, 14.12.25 14:40 Uhr
Regulatory, Headwinds
Regulatory Headwinds Challenge Hims & Hers’ Growth Strategy
boerse-global.de, 14.12.25 11:54 Uhr
Eli, Lilly’s
Eli Lilly’s Bold Return of Capital Signals Robust Growth Trajectory
boerse-global.de, 14.12.25 10:12 Uhr
Eli, Lilly
Eli Lilly: La farmacéutica que redefine el mercado con su innovación
boerse-global.de, 14.12.25 10:04 Uhr
Novo, Nordisk
Novo Nordisk Shares Face Steep Decline Amid Market Pressures
boerse-global.de, 14.12.25 09:41 Uhr
Viking, Therapeutics
Viking Therapeutics: Un valor a seguir de cara a 2026
boerse-global.de, 14.12.25 07:44 Uhr
Viking, Therapeutics
Viking Therapeutics US92686J1060
Viking Therapeutics: A 2026 Outlook Gains Momentum
boerse-global.de, 14.12.25 05:56 Uhr
Eli, Lilly
Eli Lilly: Un nuevo fármaco redefine el mercado de la obesidad y la empresa apuesta fuerte
boerse-global.de, 14.12.25 04:02 Uhr
Eli, Lilly
Eli Lilly Strengthens Market Position with Promising Trial Results and Strategic Expansion
boerse-global.de, 14.12.25 04:02 Uhr
Novo, Nordisk’s
Novo Nordisk’s Patent Shield Shows Cracks in Key Ruling
boerse-global.de, 14.12.25 03:41 Uhr
Eli, Lilly’s
Eli Lilly’s Stock Sets a New Industry Standard
boerse-global.de, 13.12.25 16:52 Uhr
Hims, Hers
Hims & Hers: Un pulso entre la expansiĂłn global y la sombra regulatoria
boerse-global.de, 13.12.25 16:32 Uhr
Eli, Lilly
Eli Lilly: La solidez de su cartera de fármacos impulsa el optimismo
boerse-global.de, 13.12.25 16:10 Uhr
Eli, Lilly’s
Eli Lilly’s Robust Pipeline Fuels Investor Confidence
boerse-global.de, 13.12.25 10:43 Uhr
Eli, Lilly
Eli Lilly redefine el horizonte en la farmacéutica con un fármaco revolucionario
boerse-global.de, 13.12.25 10:08 Uhr
Eli, Lilly’s
Eli Lilly’s Strategic Pipeline Advances Bolster Market Position
boerse-global.de, 13.12.25 04:03 Uhr
Eli, Lilly
Eli Lilly consolida su liderazgo con avances clĂnicos y una inversiĂłn millonaria
boerse-global.de, 13.12.25 04:02 Uhr
Legislative, Proposal
US Legislative Proposal Offers Respite for Novo Nordisk Amid Market Challenges
boerse-global.de, 13.12.25 03:03 Uhr
Viking, Therapeutics
Institutionelle Investoren bauen ihre Positionen bei Viking ...
